Minerva Neurosciences Inc (NERV)

Minerva Neurosciences Inc (NERV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $112M; returns 1 day -4.2%, 1 week -2.1%, 1 year -52.8%.

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company primarily focused on the development of novel therapies for central nervous system (CNS) disorders. The company currently generates no revenue from product sales or licenses, relying on financing rounds to fund its operations and extensive research and development activities.

Groups NERV belongs to

• Biotechnology
• Clinical Stage
• Clinical Stage Biotech
• CNS Disorders
• Healthcare
• Biopharmaceutical
• Neuroscience
• Pharmaceuticals
• Neurological Disorders
• Mental Health Solutions
• Life Sciences

NERV financial model: income statement, cash flow and balance sheet